Losartan Increases Bradykinin Levels in Hypertensive Humans

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Circulation

• Publication date

  2005-01-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.0000153269.07762.3BPMID 15655136
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial.

  2004cited by this paper
• Loss of Sodium Modulation of Plasma Kinins in Human Hypertension

  2004cited by this paper
• Mechanisms of angiotensin II-induced expression of B2 kinin receptors.

  2004cited by this paper
• Bradykinin Contributes to the Systemic Hemodynamic Effects of Chronic Angiotensin-Converting Enzyme Inhibition in Patients With Heart Failure

  2004cited by this paper
• Angiotensin II Type 2 Receptor–Mediated Vasodilation in Human Coronary Microarteries

  2004cited by this paper
• The role of regulated CFTR trafficking in epithelial secretion.

  2003cited by this paper
• The renin-angiotensin and the kallikrein-kinin systems.

  2003cited by this paper
• AT1-Receptor Antagonism Improves Endothelial Function in Coronary Artery Disease by a Bradykinin/B2-Receptor-Dependent Mechanism

  2003cited by this paper
• The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction.

  2003cited by this paper
• Angiotensin AT2 Receptors Directly Stimulate Renal Nitric Oxide in Bradykinin B2-Receptor–Null Mice

  2003cited by this paper
• Myocardial Uptake and Biochemical and Hemodynamic Effects of ACE Inhibitors in Humans

  2003cited by this paper
• Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

  2002cited by this paper
• Novel AT(1) receptor-independent functions of losartan.

  2002cited by this paper
• Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan.

  2002cited by this paper
• Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase*

  2002cited by this paper
• Protein kinase Cɛ contributes to regulation of the sarcolemmal Na+-K+ pump

  2001cited by this paper
• Increased AT1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness

  2001cited by this paper
• Protein kinase Cepsilon contributes to regulation of the sarcolemmal Na(+)-K(+) pump.

  2001cited by this paper
• Clinical trials report

  2001cited by this paper
• Activation of the kallikrein-kinin system by cardiopulmonary bypass in humans.

  2001cited by this paper
• The Kallikrein–Kinin System In Humans

  2001cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.

  2000cited by this paper
• Protein kinase C and phosphatase inhibitors block the ability of angiotensin I-converting enzyme inhibitors to resensitize the receptor to bradykinin without altering the primary effects of bradykinin.

  2000cited by this paper
• Kinins in humans.

  2000cited by this paper
• Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function.

  2000cited by this paper
• Bradykinin B(2) receptor antagonism attenuates blood pressure response to acute angiotensin-converting enzyme inhibition in normal men.

  2000cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

  2000cited by this paper
• Myocardial Protection by Preconditioning of Heart With Losartan, an Angiotensin II Type 1-Receptor Blocker: Implication of Bradykinin-Dependent and Bradykinin-Independent Mechanisms

  2000cited by this paper
• The angiotensin type II receptor tonically inhibits angiotensin- converting enzyme in AT2 null mutant mice.

  2000cited by this paper
• A Human Homolog of Angiotensin-converting Enzyme

  2000cited by this paper
• Effects of eprosartan versus enalapril in hypertensive patients on the renin-angiotensin-aldosterone system and safety parameters: results from a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group.

  1999cited by this paper
• Early onset salt-sensitive hypertension in bradykinin B(2) receptor null mice.

  1999cited by this paper
• Kallidin- and bradykinin-degrading pathways in human heart: degradation of kallidin by aminopeptidase M-like activity and bradykinin by neutral endopeptidase.

  1999cited by this paper
• Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists.

  1999cited by this paper
• Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation.

  1999cited by this paper
• Angiotensin II Receptor Blockade in Normotensive Subjects A Direct Comparison of Three AT 1 Receptor Antagonists

  1999cited by this paper
• Bradykinin-dependent cardioprotective effects of losartan against ischemia and reperfusion in rat hearts.

  1999cited by this paper
• Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs.

  1998cited by this paper
• Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects.

  1998cited by this paper
• Plasma bradykinin in angio-oedema.

  1998cited by this paper
• Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.

  1997cited by this paper
• Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans.

  1997cited by this paper
• Bradykinin and its metabolite, Arg-Pro-Pro-Gly-Phe, are selective inhibitors of alpha-thrombin-induced platelet activation.

  1996cited by this paper
• Role of endogenous bradykinin in human coronary vasomotor control.

  1995cited by this paper
• Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation.

  1995cited by this paper
• Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.

  1995cited by this paper
• Effects of Losartan on Angiotensin and Bradykinin Peptides and Angiotensin‐Converting Enzyme

  1995cited by this paper
• Comparison of Angiotensin‐Converting Enzyme Inhibition with Angiotensin II Receptor Antagonism in the Human Forearm

  1993cited by this paper
• Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides.

  1993cited by this paper
• The possible role of angiotensin II subtype AT2 receptors in endothelial cells and isolated ischemic rat hearts

  1993cited by this paper
• Ramiprilat Enhances Endothelial Autacoid Formation by Inhibiting Breakdown of Endothelium‐Derived Bradykinin

  1991cited by this paper
• An alternative strategy for the radioimmunoassay of angiotensin peptides using amino-terminal-directed antisera: measurement of eight angiotensin peptides in human plasma.

  1990cited by this paper
• Peptidase enzymes of the pulmonary vascular surface.

  1989cited by this paper
• Automated method for the determination of angiotensin-converting enzyme in serum.

  1987cited by this paper
• Opposite effects of captopril on angiotensin I-converting enzyme 'activity' and 'concentration'; relation between enzyme inhibition and long-term blood pressure response.

  1981cited by this paper
• Purification and properties of prolylcarboxypeptidase (angiotensinase C) from human kidney.

  1978cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• Angiotensin II Type 1 Receptor Blocker Usage Prevents Oxidative Stress and Muscle Dysfunction in HIV

  2025cites this paper
• Non‐genetic factors associated with ACE‐inhibitor and angiotensin receptor blocker‐induced angioedema

  2025cites this paper
• Bradykinin-Mediated Angioedema Induced by Drugs

  2025cites this paper
• Effects of intrarenal afferent stimulation by bradykinin on renal sympathetic nerve activity: tonic inhibition contributing to renal function

  2025cites this paper
• Oral Losartan Treatment Improves Microvascular Endothelial Function via Nitric Oxide-Dependent Mechanisms in Women With a History of Preeclampsia

  2025cites this paper
• A Case of Trauma-Related Angioedema of the Airway in a Patient on an Angiotensin Receptor Blocker

  2024cites this paper
• The bradykinin-forming cascade in anaphylaxis and ACE-inhibitor induced angioedema/airway obstruction

  2024cites this paper
• A real-world pharmacovigilance analysis of adverse events associated with irbesartan using the FAERS and JADER databases

  2024cites this paper
• Valsartan/Sacubitril induced isolated angioedema of uvula: A case report

  2024cites this paper
• A pharmacovigilance study assessing risk of angioedema with angiotensin receptor blockers using the US FDA Adverse Event Reporting System

  2024cites this paper
• A case of tongue swelling after S-1, oxaliplatin, and trastuzumab for HER2-positive gastric cancer

  2023cites this paper
• Losartan-Induced Angioedema: A Case Report

  2023cites this paper
• Bradykinin-Mediated Angioedema Induced by Commonly Used Cardiovascular Drugs

  2023cites this paper
• Comparative Risk of Angioedema With Sacubitril-Valsartan vs Renin-Angiotensin-Aldosterone Inhibitors.

  2023cites this paper
• A Case Report of Losartan Induced Angioedema

  2023cites this paper
• Orolingual angioedema during thrombolysis in acute ischemic stroke: A case report.

  2022cites this paper
• Molecular Genetic Screening in Patients With ACE Inhibitor/Angiotensin Receptor Blocker-Induced Angioedema to Explore the Role of Hereditary Angioedema Genes

  2022cites this paper
• The ACE Inhibitor Lisinopril Stimulates Melanoma Cell Invasiveness by Inducing MMP2 Secretion.

  2022cites this paper
• Mass spectrometric study of variation in kinin peptide profiles in nasal fluids and plasma of adult healthy individuals

  2022cites this paper
• Computational Study on the Inhibitory Effect of Natural Compounds against the SARS-CoV-2 Proteins

  2022cites this paper
• Utilization of Tranexamic Acid for Recurrent Angioedema after ARB Discontinuation: A Case report and Review of the Literature

  2021cites this paper
• The COVID-19 Burden or Tryptophan Syndrome: Autoimmunity, Immunoparalysis and Tolerance in a Tumorigenic Environment

  2021cites this paper
• Sacubitril/Valsartan treatment has differential effects in modulating diabetic kidney disease in db/db mice and KKAy mice when compared to valsartan treatment.

  2021cites this paper
• Do neprilysin inhibitors walk the line? Heart ameliorative but brain threatening!

  2021cites this paper
• In silico drug designing for the identification of promising antagonist hit molecules against bradykinin receptor

  2021cites this paper
• Plasma Kallikrein Contributes to Intracerebral Hemorrhage and Hypertension in Stroke-Prone Spontaneously Hypertensive Rats

  2021cites this paper
• Critical angioedema induced by a renin angiotensin system blocker in the contemporary era of increasing heart failure: A case report and commentary

  2021cites this paper
• COVID-19: imbalance of multiple systems during infection and importance of therapeutic choice and dosing of cardiac and anti-coagulant therapies

  2021influential citation
• How ACE inhibitors transformed the renin–angiotensin system

  2020cites this paper
• Kinin B1 Receptor: A Target for Neuroinflammation in Hypertension.

  2020cites this paper
• Are losartan and imatinib effective against SARS-CoV2 pathogenesis? A pathophysiologic-based in silico study

  2020cites this paper
• Gerodontology Essentials for Health Care Professionals

  2020cites this paper
• Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment

  2020cites this paper
• Hypersensitivity reaction induced with renin-angiotensin-aldosterone system blocker antihypertensive agents

  2020influential citation
• Association between the level of Bradykinin and viral infection in patient suffering from respiratory infection, renal transplant, and renal failure

  2020cites this paper
• Drug-induced chronic cough and the possible mechanism of action.

  2020cites this paper
• Medications and Oral Health: Points to Consider in Older People

  2020cites this paper
• Late-Onset Rash from Irbesartan: An Immunological Reaction

  2019cites this paper
• Pharmacotherapy in Heart Failure (I): Renin-Angiotensin-Aldosterone System (incl. ARNI), Diuretics, Digoxin and Statins

  2019cites this paper
• ACE inhibitor-mediated angioedema.

  2019cites this paper
• BNP as a Major Player in the Heart-Kidney Connection

  2019cites this paper
• Losartan Induced Acute Urticaria.

  2019cites this paper
• Neprilysin Inhibitors and Bradykinin

  2018cites this paper
• Arzneimittelassoziierte Angioödeme

  2018cites this paper
• The depressor axis of the renin-angiotensin system and brain disorders: a translational approach.

  2018cites this paper
• Analysis of related factors of orolingual angioedema after rt-PA intravenous thrombolytic therapy.

  2018cites this paper
• A score for the differential diagnosis of bradykinin- and histamine-induced head and neck swellings

  2018cites this paper
• Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure

  2018cites this paper
• Pharmacogenetics of angiotensin‐converting enzyme inhibitor‐induced angioedema

  2018cites this paper
• Phosphopeptidomics Reveals Differential Phosphorylation States and Novel SxE Phosphosite Motifs of Neuropeptides in Dense Core Secretory Vesicles

  2018cites this paper
• Monitoring Biomarkers in Patients Receiving Neprilysin Inhibitors

  2018cites this paper
• The Angiotensin-Converting-Enzyme-Induced Angioedema.

  2017cites this paper
• Cardiovascular and Diabetic Medications That Cause Bradykinin-Mediated Angioedema.

  2017cites this paper
• Kallikrein-kinin system as the dominant mechanism to counteract hyperactive renin-angiotensin system.

  2017cites this paper
• Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus

  2017cites this paper
• Long-term neprilysin inhibition — implications for ARNIs

  2017cites this paper
• The impact of age and sex on the reporting of cough and angioedema with renin–angiotensin system inhibitors: a case/noncase study in VigiBase

  2017cites this paper
• Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment

  2016cites this paper
• Angioedem uzrokovan lijekovima koji djeluju na angiotenzinski sustav

  2016cites this paper
• Therapeutic modulation of tissue kallikrein expression

  2016cites this paper
• Optimizing inhibition of the renin-angiotensin system in hypertension.

  2016cites this paper
• Evidenz und Evidenzlücken für medikamentös zu behandelnde, nicht-tumoröse Erkrankungen im Gebiet der HNO-Heilkunde

  2016cites this paper
• Inhibiteurs du système rénine-angiotensine

  2016cites this paper
• Evidence and evidence gaps of medical treatment of non-tumorous diseases of the head and neck

  2016cites this paper
• The Mechanism of Action of LCZ696.

  2016cites this paper
• Bradykinin-mediated angioedema.

  2016cites this paper
• Nitric oxide up-regulates endothelial expression of angiotensin II type 2 receptors.

  2016cites this paper
• Combination of angiotensin-(1–7) with perindopril is better than single therapy in ameliorating diabetic cardiomyopathy

  2015cites this paper
• Role of neprilysin inhibitor combinations in hypertension: insights from hypertension and heart failure trials.

  2015cites this paper
• Angioedema induced by cardiovascular drugs: new players join old friends

  2015cites this paper
• Treatment of angiotensin receptor blocker‐induced Angioedema: A case series

  2015cites this paper
• Antioxidant and antithrombotic therapies for diabetic kidney disease.

  2015cites this paper
• Renin angiotensin system blockers-associated angioedema in the Thai population: analysis from Thai National Pharmacovigilance Database.

  2015cites this paper
• Expanding Saga of the Renin-Angiotensin System: The Angiotensin II Counter-Regulatory AT2 Receptor Pathway.

  2015influential citation
• Azilsartan is associated with increased circulating angiotensin-(1-7) levels and reduced renovascular 20-HETE levels.

  2015cites this paper
• Untersuchung des Mechanismus der Bradykinin Rezeptor 1 vermittelten peripheren Arteriogenese im Hinterlauf-Ligaturmodell der Maus

  2015cites this paper
• Critical insights into the beneficial and protective actions of the kallikrein-kinin system.

  2015cites this paper
• Cardiovascular drugs-induced oral toxicities: A murky area to be revisited and illuminated.

  2015influential citation
• Orolingual angiodema associated with alteplase treatment of acute stroke: a reappraisal.

  2015cites this paper
• Prospective Comparison of ARNi with ACE-I to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF): paragon of a study or further investigation paramount?

  2015cites this paper
• Angiotensin-(1-7)/Mas Axis Compensates Absent Bradykinin in Bdkrb2 -/- and Klkb1 -/- Mice to Regulate Thrombosis Risk

  2014cites this paper
• Drug-induced visceral angioedema

  2014cites this paper
• Clinical Relevance of Local Renin Angiotensin Systems

  2014cites this paper
• Vasopressor meets vasodepressor: The AT1-B2 receptor heterodimer.

  2014cites this paper
• Recurrent angioedema after naproxen use in a patient stabilized with losartan.

  2014cites this paper
• Orolingual angioedema after alteplase therapy of acute ischaemic stroke: incidence and risk of prior angiotensin‐converting enzyme inhibitor use

  2014cites this paper
• Phenotype Standardization of Angioedema in the Head and Neck Region Caused by Agents Acting on the Angiotensin System

  2014cites this paper
• Angioedèmes bradykiniques en Haute‐Normandie : étude rétrospective de 56 cas

  2014influential citation
• Intermittent Losartan Administration Triggers Cardiac Post-Conditioning in Isolated Rat Hearts: Role of BK2 Receptors

  2014cites this paper
• Orolingual angioedema associated with olmesartan use after recombinant tissue plasminogen activator treatment of acute stroke.

  2014cites this paper
• Aging and Remodeling of the RAS and RAAS and Related Pathways: Implications for Heart Failure Therapy

  2014cites this paper
• Phénotypes biologiques de l'angioedème à kinine

  2014cites this paper
• Angioedema: General Overview

  2014cites this paper
• Positive house dust mite skin test in a nonatopic patient with scabies.

  2014cites this paper
• Angioedema: General Overview

  2014cites this paper
• Is Olmesartan-Induced Angioedema Triggered by Angiotensin Converting Enzyme Inhibition and Kinin Peptides? A Rare Case Olmesartana Bağli Anjiyoödem, Anjiyotensin Dönüştürücü Enzim İnhibisyonu ve Kinin Peptidazlar Tarafindan Tetiklenir mi? Nadir Bir Olgu

  2014cites this paper
• Characterization of Prolylcarboxypeptidase Expression Pattern in Rat Cardiomyocytes in Nutrition Overload Conditions

  2014cites this paper
• Direct regulation of ENaC by bradykinin in the distal nephron. Implications for renal sodium handling

  2014cites this paper
• Kinin receptors in vascular biology and pathology.

  2014cites this paper
• Eczematous reactions due to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers

  2013cites this paper